Trial · NCT03069677
Music vs Midazolam During Preop Nerve Block Placement
NCT03069677, Phase 3, Completed, University of Pennsylvania; results first posted 2019-09-10
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Music vs Midazolam During Preop Nerve Block Placement. Trials, record NCT03069677. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03069677
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Music vs Midazolam During Preop Nerve Block Placement
- NCT number
- NCT03069677
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 160 participants, actual
- Lead sponsor
- University of Pennsylvania
- Conditions
- Anxiety, Peripheral Nerve Block
- Interventions
- music, Midazolam
- First posted
- 2017-03-03
- Last updated
- 2019-09-10
- Results first posted
- 2019-09-10
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Anxiety Levels | 1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after) | Spielberger State-Trait Anxiety Inventory 6 Scale range is from 20 to 80. Higher the score, the higher the anxiety level is. |
| Primary | Change in STAI-6 Scores From Post to Pre. | 1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after) | Spielberger State-Trait Anxiety Inventory 6 Scale range is from 20 to 80. Higher the score, the higher the anxiety level is. |
| Secondary | Patient Satisfaction Scores of the Experience During Procedure | immediately after nerve block placement (less than 1 minute after) | survey which assess satisfaction on a 10-point numeric rating scale Scale ranges from 0 to 10. A higher number indicates a higher satisfaction |
| Secondary | Provider Satisfaction Scores of the Experience During Procedure | immediately after nerve block placement (less than 1 minute after) | survey which assess satisfaction on a 10-point numeric rating scale Scale ranges from 0 to 10. A higher number indicates a higher satisfaction |
| Secondary | Evaluation of Difficulties in Communication From Provider to Patient and Patient to Provider | immediately after nerve block placement (less than 1 minute after) | surveyed on a 5-point Likert scale Scale ranges from 1 to 5; the higher the number, the more difficult it is to communicate. |
| Secondary | Block Times | immediately after nerve block placement (less than 1 minute after) | differences amongst music and midaz group |
Source ClinicalTrials.gov
Outcomes6
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Anxiety Levels | 1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after) | there was incomplete collection of data and patients dropped out which resulted in 77 total analyzed participants in this group | score on a scale | MEDIAN |
| PRIMARY | Change in STAI-6 Scores From Post to Pre. | 1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after) | there was incomplete collection of data and patients dropped out which resulted in 77 total analyzed participants in this group | score on a scale | MEAN |
| SECONDARY | Patient Satisfaction Scores of the Experience During Procedure | immediately after nerve block placement (less than 1 minute after) | there was incomplete collection of data and patients dropped out which resulted in 77 total analyzed participants in this group | units on a scale | MEDIAN |
| SECONDARY | Provider Satisfaction Scores of the Experience During Procedure | immediately after nerve block placement (less than 1 minute after) | there was incomplete collection of data and patients dropped out which resulted in 77 total analyzed participants in this group | units on a scale | MEDIAN |
| SECONDARY | Evaluation of Difficulties in Communication From Provider to Patient and Patient to Provider | immediately after nerve block placement (less than 1 minute after) | there was incomplete collection of data and patients dropped out which resulted in 77 total analyzed participants in this group | score on a scale | MEDIAN |
| SECONDARY | Block Times | immediately after nerve block placement (less than 1 minute after) | there was incomplete collection of data and patients dropped out which resulted in 77 total analyzed participants in this group | minutes | MEAN |
Source ClinicalTrials.gov
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Anxiety Levels | Music Group | Pre-STAI-6 Scores | 33.3 | Inter-Quartile Range 23.3 to 41.7 | score on a scale |
| Anxiety Levels | Midazolam Group | Pre-STAI-6 Scores | 30 | Inter-Quartile Range 20 to 40 | score on a scale |
| Anxiety Levels | Music Group | Post-STAI-6 Scores | 30 | Inter-Quartile Range 20 to 40 | score on a scale |
| Anxiety Levels | Midazolam Group | Post-STAI-6 Scores | 23.3 | Inter-Quartile Range 20 to 33.3 | score on a scale |
| Change in STAI-6 Scores From Post to Pre. | Music Group | -1.6 | Standard Deviation 10.7 | score on a scale | |
| Change in STAI-6 Scores From Post to Pre. | Midazolam Group | -4.2 | Standard Deviation 11 | score on a scale | |
| Patient Satisfaction Scores of the Experience During Procedure | Music Group | 8 | Inter-Quartile Range 5 to 9 | units on a scale | |
| Patient Satisfaction Scores of the Experience During Procedure | Midazolam Group | 9 | Inter-Quartile Range 7 to 10 | units on a scale | |
| Provider Satisfaction Scores of the Experience During Procedure | Music Group | 9 | Inter-Quartile Range 8 to 10 | units on a scale | |
| Provider Satisfaction Scores of the Experience During Procedure | Midazolam Group | 10 | Inter-Quartile Range 8 to 10 | units on a scale |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Music Group | 80 | |
| Overall Study | STARTED | Midazolam Group | 80 | |
| Overall Study | COMPLETED | Music Group | 77 | |
| Overall Study | COMPLETED | Midazolam Group | 77 | |
| Overall Study | NOT COMPLETED | Music Group | 3 | |
| Overall Study | NOT COMPLETED | Midazolam Group | 3 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Music Group | 0 | 77 |
| Total, all-cause mortality | Midazolam Group | 0 | 80 |
| Total, other adverse events | Music Group | 0 | 77 |
| Total, other adverse events | Midazolam Group | 0 | 80 |
| Total, serious adverse events | Music Group | 0 | 77 |
| Total, serious adverse events | Midazolam Group | 0 | 80 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 31320504 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Music Group vs Midazolam Group: deaths from any cause | Trial comparisons |
| Music Group vs Midazolam Group: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03069677
GET https://conductscience.org/api/trials/v1/NCT03069677/registered